Thyroid Neoplasms Clinical Trial
Official title:
Is the Routine Pressure Dressing After Thyroidectomy Necessary? A Prospective Randomized Controlled Study
Thyroidectomy is an operation that is commonly performed. After an operation a pressure
dressing by Hypafix is usually used due to the belief that it will help to reduce
complications such as post-operative bleeding or haematoma. However, the practice is
uncomfortable to patients and makes it hard to detect early haematomas.
We carried out a prospective randomised study to study the role of pressure dressing after
thyroid surgery by evaluating the amount of fluids collected in the operative bed by
ultrasonography compared with normal dressing.
| Status | Completed |
| Enrollment | 116 |
| Est. completion date | September 2007 |
| Est. primary completion date | August 2007 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patients underwent thyroidectomy in Srinagarind hospital, Khonkaen University Exclusion Criteria: - Patients with cervical lymph nodes metastases requiring neck dissection - Patients that tissue pathology shown anaplastic carcinoma - Patients with clinical or laboratory indicators of coagulation disorders |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Thailand | Deapartment of Otolaryngology, Srinagarind Hospital, Khonkaen University | Muang | Khonkaen |
| Lead Sponsor | Collaborator |
|---|---|
| Khon Kaen University |
Thailand,
Abbas G, Dubner S, Heller KS. Re-operation for bleeding after thyroidectomy and parathyroidectomy. Head Neck. 2001 Jul;23(7):544-6. — View Citation
Agarwal A, Mishra SK. Post-thyroidectomy haemorrhage: an analysis of critical factors in successful management. J Indian Med Assoc. 1997 Jul;95(7):418-9, 433. — View Citation
Cichon S, Anielski R, Orlicki P, Krzesiwo-Stempak K. [Post-thyroidectomy hemorrhage]. Przegl Lek. 2002;59(7):489-92. Polish. — View Citation
FALCAO P. [Use of a compressive-compensed dressing in thyroid surgery]. Rev Bras Otorrinolaringol. 1951 May-Jun;19(3A):88-90. Undetermined Language. — View Citation
FALCAO P. [Use of compensated pressure dressing in thyroid surgery]. Rev Paul Med. 1951 Jul;39(1):64-6. Undetermined Language. — View Citation
Palestini N, Tulletti V, Cestino L, Durando R, Freddi M, Sisti G, Robecchi A. [Post-thyroidectomy cervical hematoma]. Minerva Chir. 2005 Feb;60(1):37-46. Italian. — View Citation
Shaha AR, Jaffe BM. Practical management of post-thyroidectomy hematoma. J Surg Oncol. 1994 Dec;57(4):235-8. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | amount of fluids collected in the operative bed by ultrasonography | participants will be followed for the duration of hospital stay, an expected average of 4 days | No | |
| Secondary | Days retained drains | participants will be followed for the duration of hospital stay, an expected average of 4 days | No | |
| Secondary | days of hospital stay | participants will be followed for the duration of hospital stay, an expected average of 4 days | No | |
| Secondary | complication (bruise,bleeding,wound dehiscence) | participants will be followed for the duration of hospital stay, an expected average of 4 days | Yes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00537095 -
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
|
Phase 2 | |
| Recruiting |
NCT04139096 -
Genetic Susceptibility to Radiation Induced Thyroid Cancer
|
||
| Completed |
NCT00754182 -
Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision
|
N/A | |
| Completed |
NCT00094055 -
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
|
Phase 2 | |
| Completed |
NCT00148213 -
Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
|
N/A | |
| Recruiting |
NCT06398795 -
Dual-port Trans-subclavian Thyroid Endoscopic Surgery
|
N/A | |
| Recruiting |
NCT01005654 -
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
|
||
| Active, not recruiting |
NCT05579782 -
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
|
N/A | |
| Completed |
NCT01437254 -
To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer
|
Phase 1 | |
| Recruiting |
NCT03160274 -
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
|
||
| Completed |
NCT00984282 -
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
|
Phase 3 | |
| Completed |
NCT01292044 -
The Role of Elastography in the Diagnosis of Thyroid Nodules
|
N/A | |
| Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
| Active, not recruiting |
NCT02418247 -
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
|
Phase 2/Phase 3 | |
| Completed |
NCT00467506 -
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
|
Phase 2 | |
| Completed |
NCT02430714 -
Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
|
||
| Recruiting |
NCT04396912 -
Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
|
||
| Enrolling by invitation |
NCT04411290 -
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
|
||
| Recruiting |
NCT04410601 -
Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT
|
N/A | |
| Completed |
NCT03469310 -
Minimizing Narcotic Analgesics After Endocrine Surgery
|
Phase 4 |